Literature DB >> 15153063

Clinical and socioeconomic correlates of insomnia.

James K Walsh1.   

Abstract

Insomnia is characterized by difficulty falling asleep (sleep onset disturbance), difficulty staying asleep (sleep maintenance disturbance), or poor quality (nonrestorative) sleep, leading to impairment of next-day functioning, including psychological distress. Published prevalence estimates of insomnia vary considerably, very likely due to differences in definitions, study setting, and data collection methods. However, estimates based on large population-based surveys provide a rather constant prevalence rate for chronic insomnia in the United States of about 10% (approximately 25 million people). Chronic insomnia is associated with numerous physical and psychiatric conditions and is more common in women and the elderly. Although it is often perceived as a symptom of depression, insomnia is also a precursor of depression and is associated with a substantial increase in the relative risk of major depression. Chronic insomnia is correlated with impaired mood, subjective functioning, and quality of life and, in some cases, with increased daytime sleepiness and accident risk. Those reporting insomnia have higher rates of absenteeism and health care utilization. Direct costs of insomnia have been estimated to be $13.9 billion annually, with a large majority of costs attributable to nursing home care. Chronic insomnia is a common problem, often associated with negative waking mood or function. As such, heightened clinical attention and clinical research appear warranted.

Entities:  

Mesh:

Year:  2004        PMID: 15153063

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  55 in total

Review 1.  Zolpidem extended release in insomnia: profile report.

Authors:  Marit D Moen; Greg L Plosker
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

2.  Multinomial logistic estimation of Markov-chain models for modeling sleep architecture in primary insomnia patients.

Authors:  Roberto Bizzotto; Stefano Zamuner; Giuseppe De Nicolao; Mats O Karlsson; Roberto Gomeni
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-01-06       Impact factor: 2.745

3.  Evaluating DSM-5 Insomnia Disorder and the Treatment of Sleep Problems in a Psychiatric Population.

Authors:  Lee Seng Esmond Seow; Swapna Kamal Verma; Yee Ming Mok; Sunita Kumar; Sherilyn Chang; Pratika Satghare; Aditi Hombali; Janhavi Vaingankar; Siow Ann Chong; Mythily Subramaniam
Journal:  J Clin Sleep Med       Date:  2018-02-15       Impact factor: 4.062

4.  Sleep in bipolar patients.

Authors:  Larriany M F Giglio; Ana C Andreazza; Mônica Andersen; Keila M Ceresér; Julio C Walz; Laura Sterz; Flávio Kapczinski
Journal:  Sleep Breath       Date:  2008-11-04       Impact factor: 2.816

Review 5.  Sleep disorders and quality of life in renal transplant recipients.

Authors:  Miklos Zsolt Molnar; Marta Novak; Istvan Mucsi
Journal:  Int Urol Nephrol       Date:  2009-01-31       Impact factor: 2.370

6.  The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers.

Authors:  Meagan Daley; Charles M Morin; Mélanie LeBlanc; Jean-Pierre Grégoire; Josée Savard
Journal:  Sleep       Date:  2009-01       Impact factor: 5.849

7.  A dietary supplement to improve the quality of sleep: a randomized placebo controlled trial.

Authors:  Catherine Cornu; Laurent Remontet; Florence Noel-Baron; Alain Nicolas; Nathalie Feugier-Favier; Pascal Roy; Bruno Claustrat; Mitra Saadatian-Elahi; Behrouz Kassaï
Journal:  BMC Complement Altern Med       Date:  2010-06-22       Impact factor: 3.659

8.  Persecutory ideation and insomnia: findings from the second British National Survey of Psychiatric Morbidity.

Authors:  Daniel Freeman; Traolach Brugha; Howard Meltzer; Rachel Jenkins; Daniel Stahl; Paul Bebbington
Journal:  J Psychiatr Res       Date:  2010-10-18       Impact factor: 4.791

9.  New assessment tools that measure sleep vital signs: the SleepMed Insomnia Index and the Sleep Matrix.

Authors:  Richard K Bogan; Jo Anne Turner
Journal:  Neuropsychiatr Dis Treat       Date:  2007-08       Impact factor: 2.570

10.  Indiplon in the management of insomnia.

Authors:  Michael D Lemon; Joe D Strain; Annie M Hegg; Debra K Farver
Journal:  Drug Des Devel Ther       Date:  2009-09-21       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.